Literature DB >> 1593378

Relationship of common laboratory parameters to the activity of Crohn's disease in children.

J S Hyams1, F Mandel, G D Ferry, J D Gryboski, P M Kibort, B S Kirschner, A M Griffiths, A J Katz, J T Boyle.   

Abstract

The Pediatric Crohn's Disease Activity Index (PCDAI) has been proposed as a simple instrument to aid in the classification of patients by disease severity. The PCDAI includes subjective patient reporting of symptoms, physical examination, nutritional parameters, and several common laboratory tests (hematocrit, erythrocyte sedimentation rate, albumin). In this report we examine the relationship of each of the laboratory parameters to the PCDAI, as well as to a modified Harvey-Bradshaw Index score and physician global assessment of disease activity. Data were gathered from the clinical and laboratory observations from 133 children and adolescents at 12 pediatric gastroenterology centers in North America. A statistically significant relationship (p less than 0.05) was noted between each of the laboratory tests and the PCDAI for patients with either disease limited to the small bowel or in those with colonic involvement. For patients with disease limited to the small bowel, a statistically significant (p less than 0.05) relationship was also noted between the three laboratory parameters and the modified Harvey-Bradshaw Index and global assessment. For patients with large-bowel involvement, the erythrocyte sedimentation rate was statistically related to the modified Harvey-Bradshaw Index and global assessment (p less than 0.01), as was hematocrit to global assessment (p less than 0.01). Although the laboratory parameters used in the PCDAI appear to generally reflect disease activity in most patients, no single laboratory test is adequate to reflect disease activity in all patients. Future work will need to identify additional laboratory measures to reflect the inflammatory process and serve as important adjuncts in the assessment of disease activity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1593378     DOI: 10.1097/00005176-199202000-00017

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  8 in total

1.  Gender differences in the social functioning of adolescents with inflammatory bowel disease.

Authors:  Laura M Mackner; Kathryn Vannatta; Wallace V Crandall
Journal:  J Clin Psychol Med Settings       Date:  2012-09

2.  Infliximab Dosing Strategies and Predicted Trough Exposure in Children With Crohn Disease.

Authors:  Adam Frymoyer; Travis L Piester; K T Park
Journal:  J Pediatr Gastroenterol Nutr       Date:  2016-05       Impact factor: 2.839

3.  Oral human immunoglobulin for children with autism and gastrointestinal dysfunction: a prospective, open-label study.

Authors:  Cindy K Schneider; Raun D Melmed; Leon E Barstow; F Javier Enriquez; James Ranger-Moore; James A Ostrem
Journal:  J Autism Dev Disord       Date:  2006-11

4.  Compare risk factors associated with postoperative infectious complication in Crohn's disease with and without preoperative infliximab therapy: a cohort study.

Authors:  Shasha Tang; Xue Dong; Wei Liu; Weilin Qi; Lingna Ye; Xiaoyan Yang; Qian Cao; Xiaolong Ge; Wei Zhou
Journal:  Int J Colorectal Dis       Date:  2020-02-14       Impact factor: 2.571

5.  Effect of exclusive enteral nutrition on bone turnover in children with Crohn's disease.

Authors:  Kylie E Whitten; Steven T Leach; Timothy D Bohane; Helen J Woodhead; Andrew S Day
Journal:  J Gastroenterol       Date:  2009-12-03       Impact factor: 7.527

6.  Growth hormone treatment for growth failure in pediatric patients with Crohn's disease.

Authors:  Melvin B Heyman; Elizabeth A Garnett; Janet Wojcicki; Neera Gupta; Cheryl Davis; Stanley A Cohen; Benjamin D Gold; Barbara S Kirschner; Robert N Baldassano; George D Ferry; Harland S Winter; Selna Kaplan
Journal:  J Pediatr       Date:  2008-06-27       Impact factor: 4.406

7.  Correlation of MMP-3 and MMP-9 with Crohn's disease activity in children.

Authors:  Anna Kofla-Dlubacz; Malgorzata Matusiewicz; Malgorzata Krzystek-Korpacka; Barbara Iwanczak
Journal:  Dig Dis Sci       Date:  2011-10-14       Impact factor: 3.199

8.  Effect of exclusive enteral nutrition on the microbiota of children with newly diagnosed Crohn's disease.

Authors:  Nadeem O Kaakoush; Andrew S Day; Steven T Leach; Daniel A Lemberg; Shaun Nielsen; Hazel M Mitchell
Journal:  Clin Transl Gastroenterol       Date:  2015-01-15       Impact factor: 4.488

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.